Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionMHC class Ib protein binding

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

4.80e-0816474GO:0023029
GeneOntologyMolecularFunctionMHC class Ib receptor activity

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.02e-0719474GO:0032394
GeneOntologyMolecularFunctionimmune receptor activity

KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.36e-06165476GO:0140375
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

OR5T3 OR6B3 KIR2DS2 OR5T2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1 OR6B2 OR5F1

9.59e-0613534713GO:0004888
GeneOntologyMolecularFunctionMHC class I receptor activity

KIR2DS5 KIR3DL1 KIR3DS1

9.73e-0618473GO:0032393
GeneOntologyMolecularFunctionMHC protein binding

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.04e-0558474GO:0042287
GeneOntologyMolecularFunctionodorant binding

OR5T3 OR6B3 OR5T2 OR6B2 OR5F1

1.19e-05127475GO:0005549
GeneOntologyMolecularFunctioninhibitory MHC class I receptor activity

KIR2DS5 KIR3DL1

3.53e-0412472GO:0032396
GeneOntologyMolecularFunctionbasal RNA polymerase II transcription machinery binding

ZNF326 ELP4 FOXF2

5.04e-0466473GO:0001099
GeneOntologyMolecularFunctionbasal transcription machinery binding

ZNF326 ELP4 FOXF2

5.04e-0466473GO:0001098
GeneOntologyMolecularFunctionolfactory receptor activity

OR5T3 OR6B3 OR5T2 OR6B2 OR5F1

3.33e-03431475GO:0004984
GeneOntologyMolecularFunctionRNA polymerase II complex binding

ZNF326 ELP4

3.80e-0339472GO:0000993
GeneOntologyBiologicalProcessimmune response-regulating signaling pathway

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.49e-066154910GO:0002764
GeneOntologyBiologicalProcessregulation of immune response

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 DCST1 KIR3DS1

3.73e-0510854911GO:0050776
Domainig

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.45e-111904910PF00047
DomainImmunoglobulin

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.45e-111904910IPR013151
DomainIG

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.14e-074214910SM00409
DomainIg_sub

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.14e-074214910IPR003599
DomainIg-like_dom

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.87e-075034910IPR007110
DomainIG_LIKE

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1

4.49e-06491499PS50835
DomainIg-like_fold

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.21e-057064910IPR013783
DomainFA58C

CNTNAP3B CPXM2 CNTNAP3

2.18e-0521493SM00231
DomainFA58C_3

CNTNAP3B CPXM2 CNTNAP3

2.18e-0521493PS50022
DomainFA58C_1

CNTNAP3B CPXM2 CNTNAP3

2.18e-0521493PS01285
DomainFA58C_2

CNTNAP3B CPXM2 CNTNAP3

2.18e-0521493PS01286
DomainF5_F8_type_C

CNTNAP3B CPXM2 CNTNAP3

3.30e-0524493PF00754
DomainFA58C

CNTNAP3B CPXM2 CNTNAP3

3.30e-0524493IPR000421
Domain-

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

4.88e-056634992.60.40.10
DomainDUF4599

SPATA31C2 SPATA31C1

4.38e-0412492PF15371
DomainDUF4599

SPATA31C2 SPATA31C1

4.38e-0412492IPR027970
DomainGalactose-bd-like

CNTNAP3B CPXM2 CNTNAP3

1.92e-0394493IPR008979
DomainFibrinogen_a/b/g_C_dom

CNTNAP3B CNTNAP3

3.18e-0332492IPR002181
DomainFIBRINOGEN_C_2

CNTNAP3B CNTNAP3

3.18e-0332492PS51406
DomainFIBRINOGEN_C_1

CNTNAP3B CNTNAP3

3.18e-0332492PS00514
DomainOlfact_rcpt

OR5T3 OR6B3 OR5T2 OR6B2 OR5F1

3.59e-03393495IPR000725
DomainLAM_G_DOMAIN

CNTNAP3B CNTNAP3

4.46e-0338492PS50025
DomainLaminin_G_2

CNTNAP3B CNTNAP3

4.94e-0340492PF02210
DomainLamG

CNTNAP3B CNTNAP3

5.95e-0344492SM00282
DomainPDZ

TJP1 MAST2 PREX1

6.88e-03148493SM00228
Domain-

TJP1 MAST2 PREX1

7.14e-031504932.30.42.10
DomainPDZ

TJP1 MAST2 PREX1

7.27e-03151493PS50106
DomainPDZ

TJP1 MAST2 PREX1

7.41e-03152493IPR001478
DomainQuinoprotein_ADH-like_supfam

FBXW8 WDR27

8.53e-0353492IPR011047
DomainLaminin_G

CNTNAP3B CNTNAP3

1.02e-0258492IPR001791
PathwayKEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1

4.37e-1188368M16004
PathwayKEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1

1.56e-09137368M5669
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DS2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DS1

1.03e-0746365M27151
PathwayKEGG_GRAFT_VERSUS_HOST_DISEASE

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

3.39e-0641364M13519
PathwayREACTOME_DAP12_INTERACTIONS

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.03e-0554364MM14871
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR3DL1

1.13e-04190365M8240
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.74e-04135364MM14781
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.27e-2811491019664392
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

7.60e-2812491020371502
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

7.60e-2812491019936734
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

7.60e-2812491019181658
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.29e-2713491018687225
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.29e-2713491019934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.29e-2713491019120281
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.15e-2614491019875891
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.15e-2614491019421224
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.15e-2614491015896204
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.45e-2615491020082646
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.45e-2615491020643584
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.45e-2615491019326408
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.45e-2615491019926642
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.45e-2615491019850842
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.45e-2615491020207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.45e-2615491019493232
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

3.45e-2615491020356536
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491019897003
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491019279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491017868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491018643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491019309280
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491019000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491020670355
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491019527230
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491020331834
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491020652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491018668235
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.18e-2616491020210919
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.23e-2517491020173792
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.23e-2517491019218127
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.23e-2517491020483367
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.23e-2517491019968064
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.23e-2517491019169284
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.23e-2517491020878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.23e-2517491020650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.23e-2517491019450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.23e-2517491019761533
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.01e-2518491019046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.01e-2518491019846535
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.01e-2518491019630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.01e-2518491020519398
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.01e-2518491020580654
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.50e-251149918830515
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.06e-2419491018778326
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.06e-2419491018571006
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.06e-2419491020600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of ParanĂ¡.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.06e-2419491018848853
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.11e-2420491020193031
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.20e-241249920137308
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.02e-2421491019861144
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

7.37e-2422491020492596
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

8.50e-24849818681957
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

2.00e-231449919489269
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1

4.99e-231549917498266
Pubmed

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1

7.64e-2394987749980
Pubmed

Alternatively spliced forms of human killer inhibitory receptors.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

7.64e-2394988662091
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1

1.14e-221649916403292
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.27e-2229491020082482
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.42e-221749919032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DS1

2.42e-221749920173784
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1

3.82e-221049812559621
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1

4.83e-221849920200544
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

4.83e-221849920210918
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.66e-212049920426625
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.06e-2135491019683555
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

2.54e-201449818945962
Pubmed

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1 KIR3DS1

2.53e-19949718340360
Pubmed

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

8.42e-191049721206914
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

5.54e-181249717490516
Pubmed

Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DS1

5.69e-18649617882223
Pubmed

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4 KIR2DS5 KIR3DL1

3.98e-17749614607943
Pubmed

Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

3.98e-17749611169255
Pubmed

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.

KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1

3.98e-1774969430220
Pubmed

KIR haplotype content at the allele level in 77 Northern Irish families.

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1 KIR3DS1

1.59e-16849617200871
Pubmed

Human diversity in killer cell inhibitory receptor genes.

KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1

1.59e-1684969430221
Pubmed

In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.

KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

4.50e-15549519410616
Pubmed

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.50e-15549516112031
Pubmed

Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.

KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS4

4.50e-15549510424431
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

4.50e-15549518755860
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.

KIR2DS2 KIR2DS1 KIR2DS3 KIR3DL1 KIR3DS1

2.70e-14649520528243
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1

2.51e-13849515730517
Pubmed

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

KIR2DL2 KIR2DL3 KIR3DL1 KIR3DS1

3.48e-12449419522772
Pubmed

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

3.48e-12449418269867
Pubmed

Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1

3.48e-12449426542066
Pubmed

Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.48e-12449418632158
Pubmed

Study of the KIR gene profiles and analysis of the phylogenetic relationships of Rajbanshi population of West Bengal, India.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.48e-12449423354323
Pubmed

Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.

KIR2DL1 KIR2DS3 KIR3DL1 KIR3DS1

1.74e-11549416508981
Pubmed

KIR gene in ethnic and Mestizo populations from Mexico.

KIR2DL2 KIR2DS1 KIR2DS5 KIR3DS1

1.74e-11549416698429
Pubmed

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

KIR2DS2 KIR2DL1 KIR2DL3 KIR3DL1

1.74e-1154947716543
Pubmed

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.74e-11549427893413
Pubmed

Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.21e-10749415748957
Pubmed

Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.21e-10749426928464
Pubmed

Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

1.21e-10749412618911
Pubmed

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

2.42e-10849420935224
Pubmed

Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

KIR2DS2 KIR2DS1 KIR2DS3 KIR3DS1

4.36e-10949418074414
Pubmed

Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.

KIR2DS2 KIR2DL1 KIR2DS1

2.63e-09349329549293
Pubmed

Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.

KIR2DL2 KIR2DL3 KIR2DS4

2.63e-09349326031759
Pubmed

KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.

KIR2DS4 KIR3DL1 KIR3DS1

2.63e-09349319859704
InteractionKIR2DL2 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1 KIR3DS1

1.49e-1313456int:KIR2DL2
InteractionKIR2DS2 interactions

KIR2DS2 KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1

1.93e-1037456int:KIR2DS2
InteractionKIR2DS3 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS5

6.67e-1020455int:KIR2DS3
InteractionKIR3DL1 interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1

1.53e-0813454int:KIR3DL1
InteractionKIR3DP1 interactions

KIR2DS2 KIR2DL1 KIR2DS5

4.15e-084453int:KIR3DP1
InteractionKIR2DL1 interactions

KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1

4.27e-0728454int:KIR2DL1
InteractionKIR2DS5 interactions

KIR2DS2 KIR2DS3 KIR2DS5

5.71e-0616453int:KIR2DS5
InteractionKIR2DS1 interactions

KIR2DS2 KIR2DS1

2.92e-054452int:KIR2DS1
InteractionHLA-C interactions

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4

1.27e-04353456int:HLA-C
Cytoband19q13.4

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

9.80e-1979491019q13.4
Cytoband11q12.1

OR5T3 OR5T2 OR5F1

6.93e-0416149311q12.1
Cytoband2q37.3

OR6B3 OR6B2

3.10e-03774922q37.3
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 KIR3DS1

1.99e-23183810620
GeneFamilyADAM metallopeptidase domain containing|CD molecules

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

1.31e-06394388471
GeneFamilyOlfactory receptors, family 5

OR5T3 OR5T2 OR5F1

1.67e-03112383152
GeneFamilyPDZ domain containing

TJP1 MAST2 PREX1

3.96e-031523831220
GeneFamilyOlfactory receptors, family 6

OR6B3 OR6B2

5.14e-0351382153
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

AFAP1 PREX1 PHLDB2

9.17e-03206383682
CoexpressionKAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1

2.43e-1449478M40909
CoexpressionGSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN

KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1

4.63e-08190477M4662
CoexpressionGSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN

KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DS1

1.47e-06199476M9885
CoexpressionHE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL

KIR2DL1 KIR2DL3 KIR3DL1

4.33e-0618473M45763
CoexpressionGSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN

DENND5B INA CPXM2 DCST1 FOXF2

2.91e-05200475M9935
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 PLPP1 HOXD10 TLL1 CNTNAP3 PHLDB2

7.20e-101904476e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCellNS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1 PHLDB2

7.20e-07171445adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DLGAP2 AFAP1 TLL1 CNTNAP3 PHLDB2

8.07e-0717544543be63976da5ad0764d24d90919a77ce46068f52
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTNAP3B AFAP1 TLL1 CNTNAP3 KIR2DL1

9.28e-0718044527e8bbee388e64dd79d70b160b76d45b1f398006
ToppCell5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DLGAP2 PLPP1 TLL1 CNTNAP3 PHLDB2

1.03e-06184445453295362888c9a59d0e73c7a5b15914c50ff591
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 HOXD10 TLL1 CNTNAP3

1.06e-06185445f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTNAP3B CPXM2 PLPP1 TLL1 CNTNAP3

1.06e-06185445a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCellFetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 INA CNTNAP3 UNC13A

1.15e-06188445c4c3b21ab723b0e9beff9ec84f8d68485f771528
ToppCellEndothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 HOXD10 TLL1 CNTNAP3

1.15e-0618844580910dcbb51990f2baed240f319456c0d3fa2065
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 PLPP1 TLL1 PHLDB2

1.15e-06188445aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 CPXM2 HOXD10 CNTNAP3

1.18e-061894450d18ea72bd58d32a8ab9a61cf97f5786642f804b
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 HOXD10 TLL1 CNTNAP3

1.18e-0618944555a1776a4ce049959b3f13a43744c7314bc1f00a
ToppCell5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CPXM2 PLPP1 HOXD10 TLL1 CNTNAP3

1.21e-061904456b704deeb44e1ffa10e604d0e5612b022f6cd9a6
ToppCellControl-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class

CNTNAP3B DLGAP2 PLPP1 TLL1 PHLDB2

1.27e-06192445f95fb188aa642f3d0618242a770e7c4b70544adb
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

AFAP1 FOS PCNX1 KIR2DL3 KIR3DL1

1.27e-06192445930319cbd82b9e54864147ffcdc8bd0ea7b937be
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

AFAP1 FOS PCNX1 KIR2DL3 KIR3DL1

1.27e-06192445c7bcebcb88a25b2c97d798120efa9d5958e7f798
ToppCellCOPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class

CNTNAP3B DLGAP2 PLPP1 TLL1 PHLDB2

1.31e-0619344525bdc557055b5bce6a21f8696b48e991c696b979
ToppCellControl-Endothelial-Lymphatic|Control / Disease state, Lineage and Cell class

CNTNAP3B DLGAP2 PLPP1 TLL1 PHLDB2

1.31e-0619344564d19be73e5432d491436a01da5de5c926b615a9
ToppCellnucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CNTNAP3B DLGAP2 PLPP1 TLL1 CNTNAP3

1.34e-06194445f772a9f9ef8635aeaeb8b022dbb94e9672b36ead
ToppCellnucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CNTNAP3B DLGAP2 PLPP1 TLL1 CNTNAP3

1.34e-061944455d2b3ed5374e2ab10c1c7eb3a03139fc95036a48
ToppCellnucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CNTNAP3B DLGAP2 PLPP1 TLL1 CNTNAP3

1.34e-061944453b73f2d305a7566f7ab567e5f18c82cd3d80e32c
ToppCellParenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CNTNAP3B CPXM2 PLPP1 HOXD10 CNTNAP3

1.45e-06197445ad4a3b5da2190be9495382a2952991e1de9f190d
ToppCell5'-Adult-LymphNode-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CPXM2 PLPP1 HOXD10 TLL1 CNTNAP3

1.48e-06198445d7e15e61b6018e4c36461c9471ee29601929925c
ToppCellBronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CNTNAP3B DLGAP2 HOXD10 TLL1 CNTNAP3

1.48e-06198445b3a020522e064bb61949d38e442f24026e339364
ToppCellBronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CNTNAP3B DLGAP2 HOXD10 TLL1 CNTNAP3

1.48e-06198445fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCellBronchial-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CNTNAP3B DLGAP2 PLPP1 HOXD10 TLL1

1.56e-06200445c59f262b2b0a7e7dcb2940d1e466f98db6c56625
ToppCellBronchial-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CNTNAP3B DLGAP2 PLPP1 HOXD10 TLL1

1.56e-06200445e50ef394e3284a8323bfd60575b262b2be422aea
ToppCellCOVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CNTNAP3B DLGAP2 TLL1 CNTNAP3

1.38e-05148444f777aa1674e898e2594b2b7c029d3d05dda04df9
ToppCellFLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster

DDX60L KIR2DL1 KIR2DL2 KIR3DL1

1.83e-0515944497c8e16a7ac10ebba96daee97f9fb1d4a404f23b
ToppCellFLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster

DDX60L KIR2DL1 KIR2DL2 KIR3DL1

1.83e-05159444fe2a9f79b058e89214256e736f6e266830cdfa28
ToppCellInfluenza_Severe-gd_T|World / Disease group and Cell class

CNTNAP3B CNTNAP3 KIR2DL3 KIR3DL1

1.92e-05161444b3cdaed4d58d57e3c5dbc904a09388f3bf949407
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTNAP3B AFAP1 TLL1 CNTNAP3

2.21e-05167444d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCellEndothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

CNTNAP3B DLGAP2 CPXM2 HOXD10

2.32e-0516944495c617143e1fbdd1d55a93ffdcc210e0be37cf2f
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SYCP2 KIR2DL1 KIR2DL3 KIR3DL1

2.32e-05169444a3234904d7ff8f451ca894e93badd61d75e3cd2a
ToppCellEndothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

CNTNAP3B DLGAP2 HOXD10 TLL1

2.32e-051694448889c9e8af1ab0b093d57b69abd80b59b3461be9
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CNTNAP3B DLGAP2 CPXM2 TLL1

2.37e-05170444dcc64b73134e89ae37990d4878813b86ce91dae9
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CNTNAP3B DLGAP2 CPXM2 TLL1

2.37e-051704446035c92cd39c5ac54e7ec57d94888ee19f574639
ToppCellASK454-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

KIR2DL1 KIR2DL2 KIR3DL1 PREX1

2.37e-0517044484705434234bf2fbb5256bd5a1f6ab54c01c5a51
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CNTNAP3B DLGAP2 CPXM2 TLL1

2.37e-05170444c8c42eda44b61440c96b202e7f54650046eb95d3
ToppCellASK454-Immune-NK_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

KIR2DL1 KIR2DL2 KIR3DL1 PREX1

2.48e-05172444c9e738c3540ee09b08805b1cdb66b4a0d9d40d33
ToppCellEndothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

CNTNAP3B DLGAP2 CPXM2 CNTNAP3

2.48e-05172444d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 TLL1 CNTNAP3

2.54e-05173444dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCellEndothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

DLGAP2 PLPP1 HOXD10 TLL1

2.54e-05173444a81992965137195d20fc498f750975303961a828
ToppCellCOVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CNTNAP3B DLGAP2 TLL1 CNTNAP3

2.78e-05177444326fde0734ef0d7272693966d346ca479b9d8147
ToppCellmetastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass

DLGAP2 CPXM2 TLL1 CNTNAP3

2.78e-0517744471bf5d4bc67bda37a0499e5ec01af7dd5254041d
ToppCellPCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B DLGAP2 HOXD10 CNTNAP3

2.90e-0517944435fe9961e228ce255e3317fc244efa35b5adbf8b
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CNTNAP3B PLPP1 TLL1 PREX1

2.90e-051794448f9e538c822940785130297712b75131812a4603
ToppCellPCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B DLGAP2 HOXD10 CNTNAP3

2.90e-05179444ab3d08b51cd7a37582305615ee221c7a2af83b40
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIR2DL1 KIR2DL3 KIR3DL1 PREX1

2.97e-05180444512c005567ad9c78cc5cc83862fc1219bcf49f60
ToppCellEpithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 INA UNC13A

3.10e-0518244457bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLPP1 TLL1 CNTNAP3 PHLDB2

3.10e-05182444fd786c88826ad3d5cc5c3d80f8e392d6be1b5267
ToppCell5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLPP1 HOXD10 TLL1 CNTNAP3

3.17e-051834442d0d3b486498a7903fa9a1f48b189291da49c430
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 HOXD10 TLL1

3.17e-05183444bc98df870de65aff6dab295c24cbc199c7f2aa15
ToppCellPCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B DLGAP2 HOXD10 CNTNAP3

3.30e-051854443be9e05b929ac4d956b1d53284072f668a6c1959
ToppCellControl-T_cells-NK_cells|Control / group, cell type (main and fine annotations)

KIR2DL1 KIR2DL3 KIR3DL1 PREX1

3.30e-05185444755c0998c729f462399f1d5e88adf4bfae31be30
ToppCellPCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B DLGAP2 HOXD10 CNTNAP3

3.30e-05185444c3dd64a726cb8a1fe048683c266b7532a714a52e
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.37e-05186444e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.37e-051864441590fe72badffc79f1d390deb3207116ac2281bb
ToppCellFetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 INA UNC13A

3.37e-05186444b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCellpdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CNTNAP3B DLGAP2 PLPP1 CABIN1

3.44e-051874447e376831a11ee72ed87abcdac631ca46ae29c250
ToppCellmetastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass

CNTNAP3B CPXM2 TLL1 CNTNAP3

3.44e-051874442713f526f86911fbbf6c7a3e69230f2e6bde31c3
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTNAP3B AFAP1 TLL1 CNTNAP3

3.44e-05187444e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 TLL1 CNTNAP3

3.44e-051874441e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells)

CNTNAP3B DLGAP2 TLL1 CNTNAP3

3.52e-051884441f40b959777d18ad88d239df8cca304f062ba04c
ToppCellCOVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type

CNTNAP3B PLPP1 TJP1 TLL1

3.52e-05188444eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 TLL1 CNTNAP3

3.52e-051884442db80767903703e7e0a1a37c598f7877a909ee94
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 TLL1 CNTNAP3

3.52e-05188444c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells)

CNTNAP3B DLGAP2 TLL1 CNTNAP3

3.52e-05188444aa69e3f44d506f5ef358a3374ac5160d847c858f
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

SYCP2 KIR2DL1 KIR2DL3 KIR3DL1

3.52e-051884440a2be6eac6fde669fbc58fd1b2e93e4acf17ddde
ToppCellCOVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type

CNTNAP3B DLGAP2 TLL1 CNTNAP3

3.59e-05189444c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3
ToppCellEndothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor

CNTNAP3B PLPP1 TLL1 CNTNAP3

3.59e-05189444fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCellCOVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type

CNTNAP3B CPXM2 TLL1 CNTNAP3

3.59e-051894447346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.67e-051904441f890be1ac8613a098b271945f25a58c3c2530ab
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor

CNTNAP3B DLGAP2 TLL1 CNTNAP3

3.67e-0519044491bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCellCOVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PLPP1 TJP1 FOS TLL1

3.67e-0519044407b675befcd1d0a9c90cb17b5d22323468325d51
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.67e-05190444d7cecf88451f736f8f3f6f4644504cf22846cd6e
ToppCellIPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class

CNTNAP3B DLGAP2 PLPP1 TLL1

3.67e-05190444ac029e73da5995221c9b9af551d85e4b835e21d6
ToppCellPSB-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL2 KIR2DL3 KIR3DL1 PREX1

3.67e-05190444e1b5d76edd4c1b95c0a7b94284a65043ab895e67
ToppCellFetal_29-31_weeks-Immune-natural_killer_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

KIR2DL1 KIR2DL3 KIR3DL1 PREX1

3.74e-051914445696e2e2db7b898a1c7ab3582ae74cb712dd5bdf
ToppCellChildren_(3_yrs)-Immune-natural_killer_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

KIR2DL1 KIR2DL3 KIR3DL1 PREX1

3.74e-051914449b8b64a36e27a2523b8730c7922fd7ad865a021e
ToppCellCOVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type

CNTNAP3B CPXM2 TLL1 CNTNAP3

3.82e-05192444c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCellIPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class

CNTNAP3B DLGAP2 PLPP1 TLL1

3.82e-051924442496edd8f3a41146d418879de9ee2ccc7857431f
ToppCellCOVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CNTNAP3B DLGAP2 TLL1 CNTNAP3

3.82e-05192444cbe57cda44232b183821ac633b60a2668265e616
ToppCellIPF-Endothelial|IPF / Disease state, Lineage and Cell class

CNTNAP3B CPXM2 PLPP1 TLL1

3.98e-051944449591993aa2dcba3d09a0f1ea8b8f2439c26482d6
ToppCell356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells)

CNTNAP3B CPXM2 TJP1 TLL1

3.98e-051944442e5b195e02dcd5e9432b9a98b22e0478e65b9ba2
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CNTNAP3B PLPP1 TLL1 PREX1

3.98e-0519444474a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells)

CNTNAP3B CPXM2 TJP1 TLL1

3.98e-05194444b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.98e-05194444ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KIR2DL1 KIR2DL3 KIR2DS4 KIR3DL1

3.98e-051944443a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCellIPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class

CNTNAP3B AFAP1 CPXM2 TLL1

4.06e-051954442c3ad3cb79f11119ac69c413a938d21199145040
ToppCellIPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class

CNTNAP3B AFAP1 CPXM2 TLL1

4.06e-05195444120296531bbc8080dcabacbd64733cc1dc34603a
ToppCellmetastatic_Brain-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass

FOS KIR2DL1 KIR2DL3 KIR3DL1

4.06e-05195444184471f71b8bbffec12ebb8dd6a0af589e021c02
ToppCell5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DLGAP2 PLPP1 TLL1 CNTNAP3

4.06e-05195444590c0dc0db4dc62879645ed7f61292ff97d2c7d5
ToppCelldistal-Endothelial-Lymphatic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CNTNAP3B DLGAP2 CPXM2 PHLDB2

4.06e-05195444f45c1349932ee7eb419cced8a4fdedae3610953f
ToppCellTracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DLGAP2 HOXD10 TLL1 CNTNAP3

4.14e-0519644409a7edf4a7defb7fe70d9777dd9500ee8421ff31
ToppCellTracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DLGAP2 HOXD10 TLL1 CNTNAP3

4.14e-05196444e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HOXD10 FOS CNTNAP3 FOXF2

4.14e-05196444a7adc0e0baef261d0937e4e8351321d41beca82f
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CNTNAP3B CPXM2 TLL1 CNTNAP3

4.14e-051964445609b2d93172a488b35d854298a3a4e504e17e28
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CNTNAP3B PLPP1 TLL1 PREX1

4.14e-05196444adee900dcd16dbaba15c58bdcace09ba20214950
ToppCellBL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

4.14e-05196444cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7
ComputationalNeighborhood of IL2RB

KIR2DS2 KIR2DL1 KIR2DS4 KIR3DL1

2.93e-0646244GNF2_IL2RB
ComputationalGenes in the cancer module 397.

AFAP1 TJP1 CABIN1 PREX1

1.36e-04121244MODULE_397
DrugD-Au

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1

3.98e-1277488CID000277822
DrugAa1

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1

7.40e-1283488CID009549188
Drug1c88

FOS KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

8.19e-09126487CID000444766
Drug1xa5

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4

4.22e-0893486CID000157684
DrugAC1L1AQK

KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

1.84e-07119486CID000001105
Drugpristane

KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

7.81e-07152486CID000015979
Drugglycoluril

KIR2DL1 KIR2DL2 KIR2DL3 KIR3DL1

4.72e-0653484CID000062347
DrugNSC237521

KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4

5.09e-06210486CID000428410
DrugDNTB

KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

5.99e-06216486CID000015325
DrugAb-9

KIR2DL2 KIR2DL3 KIR3DL1

1.14e-0521483CID006540280
DrugAzacitidine

PLPP1 TJP1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS4 KIR3DL1

2.46e-05415487ctd:D001374
Drug6-carboxyfluorescein diacetate

KIR2DL1 KIR2DL2 KIR2DL3

3.43e-0530483CID000151095
Drugisopentenyl diphosphate

KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5

3.72e-0589484CID000001195
Drugbunazosin

KIR2DS1 KIR2DS3 KIR2DS4

4.18e-0532483CID000002472
DrugMimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A

SYCP2 DYNC2LI1 PCNX1 ZNF318 CABIN1

5.83e-051974855302_UP
Diseaselevel of killer cell immunoglobulin-like receptor 2DS2 in blood serum

KIR2DL1 KIR2DL3

7.13e-063462OBA_2042107
Diseaserenal overload-type gout

SPATA31C2 SPATA31C1

3.55e-056462EFO_0021525
Diseaseautosomal recessive intellectual developmental disorder (implicated_via_orthology)

CNTNAP3B CNTNAP3

6.62e-058462DOID:0060308 (implicated_via_orthology)
Diseaseeosinophil cationic protein measurement

SPATA31C2 SPATA31C1

6.62e-058462EFO_0010913
Diseaseacquired immunodeficiency syndrome (is_implicated_in)

KIR2DL1 KIR3DS1

8.50e-059462DOID:635 (is_implicated_in)
Diseaselongitudinal alcohol consumption measurement

SPATA31C2 SPATA31C1

8.50e-059462EFO_0007645
Diseaseegg allergy measurement, parental genotype effect measurement

SPATA31C2 SPATA31C1

1.83e-0413462EFO_0005939, EFO_0007018
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR2DL1 KIR2DL3

2.46e-0415462EFO_0801746
Diseaseamygdala volume change measurement

SPATA31C2 SPATA31C1

2.81e-0416462EFO_0021490
Diseasemalaria (is_implicated_in)

KIR3DL1 KIR3DS1

6.42e-0424462DOID:12365 (is_implicated_in)
Diseaseresponse to tenofovir, creatinine clearance measurement

DLGAP2 OR5T3 PREX1

7.18e-04112463EFO_0007934, EFO_0009279
Diseasetuberculosis (is_implicated_in)

KIR3DL1 KIR3DS1

8.76e-0428462DOID:399 (is_implicated_in)
Diseasehepatitis C (is_implicated_in)

KIR3DL1 KIR3DS1

8.76e-0428462DOID:1883 (is_implicated_in)
DiseaseCleft palate, cleft lip

SPATA31C2 KIR2DS4 SPATA31C1 PHLDB2

9.34e-04279464EFO_0003959, HP_0000175
Diseasepursuit maintenance gain measurement

SPATA31C2 DDX60L SPATA31C1

9.41e-04123463EFO_0008433
Diseasehuman immunodeficiency virus infectious disease (is_implicated_in)

KIR3DL1 KIR3DS1

1.70e-0339462DOID:526 (is_implicated_in)
Diseaseautism spectrum disorder (implicated_via_orthology)

CNTNAP3B CNTNAP3 PREX1

1.73e-03152463DOID:0060041 (implicated_via_orthology)
DiseaseAmyotrophic Lateral Sclerosis, Sporadic

INA FOS

2.56e-0348462C1862941
DiseaseAmyotrophic Lateral Sclerosis, Familial

INA FOS

2.56e-0348462C4551993
DiseaseAMYOTROPHIC LATERAL SCLEROSIS 1

INA FOS

2.78e-0350462C1862939
Diseaseage at diagnosis, type 1 diabetes mellitus

TLL1 PHLDB2

4.24e-0362462EFO_0004918, MONDO_0005147
Diseasehearing loss

ZNF318 MAST2

4.93e-0367462EFO_0004238

Protein segments in the cluster

PeptideGeneStartEntry
RESYSDSMHSYEEFS

UNC13A

236

Q9UPW8
SAYFATGSSMTYHFQ

CNTNAP3

1001

Q9BZ76
MSFGSEHYLCSSSSY

INA

1

Q16352
SNYDSDAMSSSYESY

AFAP1

111

Q8N556
SSSTFPRMHYSSHYD

DLGAP2

156

Q9P1A6
FSNYFSAMYSSEDST

ELF3

11

P78545
LAYSYASTHRLMTDA

CPXM2

551

Q8N436
TLSCSSRSSYDMYHL

KIR2DS2

146

P43631
TLSCSSRSSYDMYHL

KIR2DL2

146

P43627
TLSCSSRSSYDMYHL

KIR2DS4

146

P43632
SLSYYHSPADSFSSM

FOS

26

P01100
TLSCSSRSSYDMYHL

KIR2DL3

146

P43628
SSAFSSTSAESDMYY

KIAA1109

1156

Q2LD37
MINSHSYSSRAYFFD

GPR137C

336

Q8N3F9
HYYGASLMFTSKSEA

DYNC2LI1

211

Q8TCX1
SGHESDTLRFYAYTM

DDX60L

176

Q5H9U9
TLSCSSRSSYDMYHL

KIR3DL1

241

P43629
RSSCDAMATHYYDLA

FBXW8

576

Q8N3Y1
QSSYCYSSRHSSLRM

PCNX1

2126

Q96RV3
TLSCSSWSSYDMYHL

KIR2DS3

146

Q14952
TLSCSSRSSYDMYHL

KIR2DS5

146

Q14953
YGTMSYALHSFASRQ

CABIN1

1146

Q9Y6J0
ASFSYMDSYNHDIRF

DCST1

391

Q5T197
ACRSDSFYSSSASMY

HOXD10

21

P28358
AEHYSSVYASSSCSM

DENND5B

141

Q6ZUT9
SYFDTRSERYHHMDS

MAST2

811

Q6P0Q8
SSSRFGHYYDASKRM

ELP4

176

Q96EB1
TLSCSSRSSYDMYHL

KIR2DL1

146

P43626
SAYFATGSSMTYHFQ

CNTNAP3B

1001

Q96NU0
SSTSLHRPMYYFLSS

OR6B2

51

Q6IFH4
LVSYMRPSSSYASDH

OR5T3

286

Q8NGG3
SSYSYVLFSIFSMHS

OR5F1

216

O95221
TLSCSSRSSYDMYHL

KIR2DS1

146

Q14954
FDSASSSYYLDMHSL

PIGS

286

Q96S52
GLHSSMSSYSLEQSY

FOXF2

366

Q12947
YSEHSRMLSYAASSQ

SPATA31C2

1101

B4DYI2
YDFDSIMHYARNTFS

TLL1

291

O43897
TLSCSSRSSYDMYHL

KIR3DS1

241

Q14943
SFYSGHSSFSMYCML

PLPP1

166

O14494
HDTMSYRDSYSECNS

PREX1

1161

Q8TCU6
FYSDHSRMLSYAASS

SPATA31C1

1106

P0DKV0
SSTSLHRPMYYFLSS

OR6B3

51

Q8NGW1
YSSSSLSHMGAYSRS

PHLDB2

241

Q86SQ0
FMYVRPSSSYASDHD

OR5T2

296

Q8NGG2
KAFYYSSSFTRHMRI

ZNF599

486

Q96NL3
SYSDVSSYSSEERFM

SYCP2

1216

Q9BX26
SMYSTDSRHTSDYED

TJP1

831

Q07157
DRHAYVYEMGSSTFS

WDR27

776

A2RRH5
ASFDAYRHYMAYAAS

ZNF318

786

Q5VUA4
RENYSSYSSFSSPHM

ZNF326

151

Q5BKZ1